Jonathan I Lieber Insider Trading $HSGX Ocugen, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jonathan I Lieber.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jonathan I Lieber. Jonathan I Lieber is VP, CFO and Treasurer in Altus Pharmaceuticals Inc. ($ALTU) and Chief Financial Officer in HISTOGENICS CORP ($HSGX) and Director in Salarius Pharmaceuticals, Inc. ($FLKS).
Jonathan I Lieber in Ocugen, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Jonathan I Lieber: Chief Financial Officer
Holdings: 5,000 shares
Current Value: $8,300
Latest Transaction: Oct 03 2018
$HSGX Market Capitalization: $28.25M
$HSGX Previous Close: $1.66
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Jonathan I Lieber in Ocugen, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALTU, HSGX, FLKS
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 03 2018 | HSGX | HISTOGENICS CORP | Lieber Jonathan I | Chief Financial Off ... | Option Exercise | D | 6.37 | 30,000 | 191,100 | 0 | |
| Oct 03 2018 | HSGX | HISTOGENICS CORP | Lieber Jonathan I | Chief Financial Off ... | Option Exercise | A | 0.57 | 130,000 | 73,840 | 130,000 | |
| Oct 03 2018 | HSGX | HISTOGENICS CORP | Lieber Jonathan I | Chief Financial Off ... | Option Exercise | D | 2.63 | 130,000 | 341,900 | 0 | |
| Oct 03 2018 | HSGX | HISTOGENICS CORP | Lieber Jonathan I | Chief Financial Off ... | Option Exercise | A | 0.57 | 50,000 | 28,400 | 50,000 | |
| Oct 03 2018 | HSGX | HISTOGENICS CORP | Lieber Jonathan I | Chief Financial Off ... | Option Exercise | D | 1.72 | 50,000 | 86,000 | 0 | |
| Oct 03 2018 | HSGX | HISTOGENICS CORP | Lieber Jonathan I | Chief Financial Off ... | Option Exercise | A | 0.57 | 28,000 | 15,904 | 28,000 | |
| Oct 03 2018 | HSGX | HISTOGENICS CORP | Lieber Jonathan I | Chief Financial Off ... | Option Exercise | D | 2.56 | 28,000 | 71,680 | 0 | |
| Oct 03 2018 | HSGX | HISTOGENICS CORP | Lieber Jonathan I | Chief Financial Off ... | Option Exercise | A | 0.57 | 110,000 | 62,480 | 110,000 | |
| Oct 03 2018 | HSGX | HISTOGENICS CORP | Lieber Jonathan I | Chief Financial Off ... | Option Exercise | D | 6.37 | 110,000 | 700,700 | 0 | |
| Feb 21 2018 | HSGX | HISTOGENICS CORP | Lieber Jonathan I | Chief Financial Off ... | Option Exercise | A | 2.63 | 130,000 | 341,900 | 130,000 | |
| Feb 15 2017 | HSGX | HISTOGENICS CORP | Lieber Jonathan I | Chief Financial Off ... | Option Exercise | A | 1.72 | 50,000 | 86,000 | 50,000 | |
| Dec 02 2016 | HSGX | HISTOGENICS CORP | Lieber Jonathan I | Chief Financial Off ... | Buy | P | 1.95 | 5,000 | 9,731 | 5,000 | 0 to 5 K |
| Mar 01 2016 | HSGX | HISTOGENICS CORP | Lieber Jonathan I | Chief Financial Off ... | Option Exercise | A | 2.56 | 28,000 | 71,680 | 28,000 | |
| Jul 06 2015 | HSGX | HISTOGENICS CORP | Lieber Jonathan I | Chief Financial Off ... | Option Exercise | A | 6.39 | 30,000 | 191,700 | 30,000 | |
| Jul 06 2015 | HSGX | HISTOGENICS CORP | Lieber Jonathan I | Chief Financial Off ... | Option Exercise | A | 6.39 | 110,000 | 702,900 | 110,000 |
Page: 1